Gastroenterology · Phila, PA
NPI
1770641581
Since 2006
Specialty
Gastroenterology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2000 Grant Ave, Suite 102
Phila, PA, 19115
Phone (215) 464-7222
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
758 services
Medicare patients, 2024
377
Average age 74
Drug cost, 2024
$202K
1,263 prescriptions
Company payments, 2025
$1,312
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Lieb was code 99214 (office e&m - established), 280 times for 192 patients. In total Michael Lieb billed 758 services in 20 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 280 | 192 | $93.12 | $26K |
| 99204 Office E&M - New | Office | 118 | 118 | $116.14 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 44 | $59.90 | $4,553 |
| 43239 Upper GI Endoscopy | Facility | 75 | 75 | $95.53 | $7,165 |
| 99223 Hospital E&M - Initial | Facility | 47 | 46 | $131.40 | $6,176 |
| 45385 Colonoscopy - Lesion Removal | Facility | 37 | 37 | $184.53 | $6,828 |
| 45378 Lower GI Endoscopy - Other | Facility | 34 | 34 | $140.24 | $4,768 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 28 | 28 | $175.30 | $4,908 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 16 | 16 | $175.54 | $2,809 |
| 45380 Lower GI Endoscopy - Other | Facility | 13 | 13 | $119.62 | $1,555 |
By year: 2022 $97K for 780 services; 2023 $89K for 772 services; 2024 $83K for 758 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Lieb prescribed most often to Medicare patients was Omeprazole, with 281 prescriptions and refills. In total Michael Lieb wrote 1,263 Medicare prescriptions that cost $202K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 281 | 365 | 66 | $1,408 |
| Pantoprazole Sodium Generic | 169 | 245 | 46 | $1,476 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 152 | 152 | 149 | $2,475 |
| Famotidine Generic | 120 | 170 | 26 | $573 |
| Linzess Linaclotide | 107 | 125 | 20 | $66K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 57 | 57 | 56 | $933 |
| Mesalamine Dr Mesalamine | 38 | 40 | Under 11 | $14K |
| Dicyclomine Hcl Generic | 35 | 39 | 13 | $630 |
| Sucralfate Generic | 28 | 28 | Under 11 | $691 |
| Procto-Med Hc Hydrocortisone | 28 | 31 | Under 11 | $329 |
| Dexlansoprazole Dr Dexlansoprazole | 22 | 24 | Under 11 | $3,843 |
| Esomeprazole Magnesium Generic | 21 | 27 | Under 11 | $1,316 |
| Loperamide Loperamide Hcl | 20 | 20 | Under 11 | $202 |
| Lansoprazole Generic | 15 | 15 | Under 11 | $41.85 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 14 | 14 | 14 | $203 |
Brand drugs: 225 claims; generic drugs: 1,038 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Lieb $1,312 ($1,312 in general payments such as food, travel and fees) from 11 companies. The largest payer was Genzyme Corporation with $213.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 8 | $213 |
| Janssen Biotech, Inc. JNJ | 7 | $197 |
| Aimmune Therapeutics, Inc. | 4 | $171 |
| Shockwave Medical, Inc JNJ | 1 | $164 |
| Abbvie Inc. ABBV | 7 | $160 |
| Gilead Sciences, Inc. GILD | 5 | $114 |
| Pfizer Inc. PFE | 5 | $96.64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $85.07 |
| QOL Medical, LLC | 2 | $47.62 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $46.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.